Cassiopea S.p.A. (OTCMKTS:CPPSF) Short Interest Update


Share on StockTwits

Cassiopea S.p.A. (OTCMKTS:CPPSF) was the target of a large decrease in short interest in the month of March. As of March 31st, there was short interest totalling 600 shares, a decrease of 66.7% from the March 15th total of 1,800 shares. Based on an average trading volume of 100 shares, the short-interest ratio is presently 6.0 days.

Shares of CPPSF remained flat at $$54.03 on Wednesday. The stock’s 50 day simple moving average is $54.03 and its 200-day simple moving average is $52.50. Cassiopea has a 52 week low of $36.62 and a 52 week high of $59.00.

About Cassiopea

Cassiopea S.p.A., a clinical-stage specialty pharmaceutical company, focuses on developing and commercializing medical dermatology products worldwide. It offers Winlevi, an antiandrogen, which has completed Phase III clinical trial for the topical treatment of acne; Breezula, a topical antiandrogen that is in Phase II clinical trial to treat androgenic alopecia; CB-06-01, a topical antibiotic, which is in Phase II clinical trial for the treatment of acne, including strains resistant to other antibiotics; and CB-06-02, a novel integrin activator that has completed Phase II clinical trial to treat genital warts.

Featured Story: What does cost of debt say about a company’s financial health?

Receive News & Ratings for Cassiopea Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cassiopea and related companies with MarketBeat.com's FREE daily email newsletter.